01 Oct 2010
Sherry Knowles spent four years as chief patent counsel at GlaxoSmithKline after more than a decade in private practice. She tells Emma Barraclough what the experience taught her about working for pharmaceutical and biotech companies
Companies in the life science sector are increasingly turning to licensing to boost their revenue streams. Richard Gering provides a guide to the deal structures they can use
Richard Willoughby of Rouse considers whether patent protection remains important for orphan drugs
July /August 2019
AI and IP: the view from above
Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International